VTYX Stock Analysis: Buy, Sell, or Hold?
VTYX - Ventyx Biosciences, Inc. Common Stock
$13.96
0.01 (0.07%)
▲
5d:
-0.07%
30d:
+54.6%
90d:
+65.8%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 26, 2026
22d
Get Alerted When VTYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VTYX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: VTYX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: VTYX is currently trading at $13.96, which is considered slightly high relative to its 30-day fair value range of $10.24 to $14.77.
Technical Outlook: Technically, VTYX is in a strong uptrend. The price is currently testing key support at $13.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VTYX is in a strong uptrend. The price is currently testing key support at $13.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$10.24 -
$14.77
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($14.14)
Fair Price Analysis
30-Day Fair Range
$10.24 -
$14.77
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.85
Resistance Level
$14.07
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-8.57
Wall Street Target
$14.14
(+1.3%)
Last updated: February 03, 2026 12:58 AM ET
Data refreshes hourly during market hours. Next update: 1:58 AM
Data refreshes hourly during market hours. Next update: 1:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 62 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
